A new diagnostic test co-developed by Memorial Sloan-Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions. read more

Read the original post:
New Diagnostic Test for Blood Cancers Will Help Doctors Tailor Treatments